B16 tumor-bearing B cell KO and WT mice were treated intratumorally with TLR-7/8 agonist or vehicle; serum was collected at various time points and analyzed for the presence of B16 tumor-specific serum IgG antibodies by ELISA as described under methods. Here, TLR7 is linked to neoplasm.